Specimen Transport Solutions Market Global Report 2026

The specimen transport solutions market size has grown strongly in recent years. It will grow from $2.43 billion in 2025 to $2.67 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to limited standardization in sample transport processes, rising demand for reliable diagnostic testing, increasing expansion of clinical laboratory networks, growing awareness of sample contamination risks, early adoption of cold chain logistics in healthcare.

The specimen transport solutions market size is expected to see rapid growth in the next few years. It will grow to $3.94 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics and personalized medicine, rising integration of digital tracking and IoT-based monitoring, expansion of biobanking and clinical research activities, growing outsourcing of laboratory testing services, and advancement in automated and temperature-controlled logistics systems. Major trends in the forecast period include rising adoption of temperature-controlled specimen transport systems to ensure sample integrity, increasing use of IoT-enabled tracking for real-time specimen monitoring, growing demand for tamper-evident and traceable transport packaging solutions, expansion of cold chain logistics for biological sample transportation, and rising integration of automated laboratory-to-lab specimen transfer systems.

The increasing diagnostic testing is expected to drive the growth of the specimen transport solutions market in the coming years. Diagnostic testing refers to medical procedures and tools used to identify diseases, conditions, or infections in individuals. The rise in diagnostic testing is attributed to advancements in medical technology that have made tests more accurate, faster, and easier to access, enabling healthcare providers to detect diseases earlier and with greater reliability. Specimen transport solutions ensure the safe, timely, and temperature-controlled movement of clinical samples from collection points to laboratories, thereby maintaining sample integrity and supporting accurate and reliable diagnostic testing outcomes. For instance, in November 2023, according to the National Health Service, a UK-based government department, in the year ending March 2023, England conducted 45 million imaging tests, representing a 2.2% increase from 44 million in the previous year. This total included 10.3 million diagnostic ultrasound tests, up 1.8%; 7.1 million CT scans, up 5.5%; and 4.1 million MRI scans, up 6.2%. Therefore, the rising diagnostic testing is driving the growth of the specimen transport solutions market.

Major companies operating in the specimen transport solutions market are focusing on developing innovative products such as portable temperature-controlled sample transport systems to enhance cold chain stability, ensure sample integrity, and improve reliability in diagnostic and clinical laboratory workflows. Portable temperature-controlled sample transport systems are compact devices or containers designed to maintain a stable, controlled temperature during the movement of biological or medical samples, ensuring their integrity and preventing degradation until they reach the laboratory or testing facility. For instance, in September 2023, Artyc Public Benefit Corporation, a US-based cold chain technology company, launched Medstow Mini, a compact battery-powered cooling container designed for temperature-stable transport of medical samples, including blood specimens. The system is engineered to maintain consistent cooling conditions throughout the supply chain, enabling reliable sample collection and delivery in clinical diagnostics, remote healthcare, and laboratory testing applications while improving efficiency and accuracy in specimen handling workflows.

In September 2023, United Parcel Service Inc., a US-based logistics and supply chain services provider, acquired MNX Global Logistics Corp. for an undisclosed amount. Through this acquisition, UPS aims to strengthen its healthcare and time-critical logistics capabilities by integrating MNX’s expertise in radio-pharmaceutical, temperature-sensitive, and urgent delivery services, thereby enhancing its end-to-end support for healthcare logistics, including specimen transport and clinical trial supply chains. MNX Global Logistics Corp. is a US-based company specializing in time-critical and temperature-sensitive shipping, including irreplaceable specimens for clinical trials and other biological materials.

Major companies operating in the specimen transport solutions market are Abbott Laboratories, Alifax S.r.l., Avantor Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Cardinal Health Inc., Copan Diagnostics Inc., Cryoport Inc., Entegris, Eppendorf SE, F. Hoffmann-La Roche Ltd., Greiner Bio-One International GmbH, Hamilton Company, Puritan Medical Products Company LLC, QIAGEN N.V., SARSTEDT AG And Co. KG, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Thermo Fisher/Patheon, United Parcel Service Inc.

North America was the dominant region in the specimen transport solutions market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in specimen transport solutions report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the specimen transport solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The specimen transport solutions market consists of revenues earned by entities by providing services such as temperature-controlled transport, scheduled sample pickup and delivery, real-time tracking, secure specimen packaging, and chain-of-custody management. The market value includes the value of related goods sold by the service provider or included within the service offering. The specimen transport solutions market also includes sales of Pneumatic tube transport systems, Temperature monitoring devices, barcode labeling and tracking systems, absorbent specimen pads and safety inserts, and refrigerated transport units. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The specimen transport solutions market research report is one of a series of new reports that provides specimen transport solutions market statistics, including specimen transport solutions industry global market size, regional shares, competitors with a specimen transport solutions market share, detailed specimen transport solutions market segments, market trends and opportunities, and any further data you may need to thrive in the specimen transport solutions industry. This specimen transport solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.